Abstract:CRISPR-Cas systems are widely used for genome engineering technologies, and in their natural setting, they play crucial roles in bacterial and archaeal adaptive immunity, protecting against phages and other mobile genetic elements. Previously we discovered bacteriophage-encoded Cas9-specific anti-CRISPR (Acr) proteins that serve as countermeasures against host bacterial immunity by inactivating their CRISPR-Cas systems 1 . We hypothesized that the evolutionary advantages conferred by anti-CRISPRs would drive the widespread occurrence of these proteins in nature 2–4 . We have identified new anti-CRISPRs using the bioinformatic approach that successfully identified previous Acr proteins 1 against Neisseria meningitidis Cas9 (NmeCas9). In this work we report two novel anti-CRISPR families in strains of Haemophilus parainfluenzae and Simonsiella muelleri , both of which harbor type II-C CRISPR-Cas systems 5 . We characterize the type II-C Cas9 orthologs from H. parainfluenzae and S. muelleri , show that the newly identified Acrs are able to inhibit these systems, and define important features of their inhibitory mechanisms. The S. muelleri Acr is the most potent NmeCas9 inhibitor identified to date. Although inhibition of NmeCas9 by anti-CRISPRs from H. parainfluenzae and S. muelleri reveals cross-species inhibitory activity, more distantly related type II-C Cas9s are not inhibited by these proteins. The specificities of anti-CRISPRs and divergent Cas9s appear to reflect co-evolution of their strategies to combat or evade each other. Finally, we validate these new anti-CRISPR proteins as potent off-switches for Cas9 genome engineering applications.

Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing

A Broad-Spectrum Inhibitor of CRISPR-Cas9

Disabling Cas9 by an anti-CRISPR DNA mimic

Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing

Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes

CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.

AcrIIA5 Suppresses Base Editors and Reduces Their Off-Target Effects

Anti-CRISPR AcrIIC5 is a dsDNA mimic that inhibits type II-C Cas9 effectors by blocking PAM recognition

Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2

A cell cycle-dependent CRISPR-Cas9 activation system based on an anti-CRISPR protein shows improved genome editing accuracy

Broad-spectrum enzymatic inhibition of CRISPR-Cas12a

A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing

Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems

Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

Inhibition mechanisms of CRISPR-Cas9 by AcrIIA17 and AcrIIA18

Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.

Temperature-Responsive Competitive Inhibition of CRISPR-Cas9

Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications